Autopsy report · NCT03801356
Threshold Response of Lumbar Selective Nerve Root Block in Predicting Good Outcome Following Lumbar Foraminotomy
Cause of deathSlow enrollment, also staffing, sites or logistics
“The study was terminated early due to a number of concurrent issues: low enrollment, limited data and COVID-19.”
Life of this trial
- Registered 5 months after it had already started.
- Ran for about 2 years 4 months before it stopped.
- 11 participants enrolled.
- Results were posted on the registry 2 years 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- The Cleveland Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Back Pain; Radiculopathy Lumbar; Degenerative Lumbar Spinal Stenosis
- Interventions
- Selective Nerve Root Block
- Participants
- 11
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Evaluating Emetine for Viral Outbreaks (EVOLVE)
“The study was terminated due to insufficient participant enrollment resulting from a lower-than-expected number of COVID-19 cases” - A Study of Deflazacort (Emflaza®) in Participants With Limb-Girdle Muscular Dystrophy 2I (LGMD2I)
“The study was terminated early due to low enrollment and missing efficacy assessment data due to missed visits related to COVID-19.” - Anti-RSV Study in Chinese Patients (ASCENT)
“The study was terminated early due to COVID-19-related enrollment disruptions, not as a result of any product safety concerns.” - Peripheral Nerve Stimulation for Back
“Due to COVID-19 and other factors this study was terminated early and the patients currently enrolled are being used as a small pilot study.” - A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
“Due to low enrollment, this study was terminated early.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.